1 September 2024 false No description of principal activity Taxfiler 2024.6 15106198business:PrivateLimitedCompanyLtd2024-09-012025-08-31 151061982024-08-31 151061982024-09-012025-08-31 15106198business:AuditExempt-NoAccountantsReport2024-09-012025-08-31 15106198business:FilletedAccounts2024-09-012025-08-31 151061982025-08-31 15106198business:Director12024-09-012025-08-31 15106198business:RegisteredOffice2024-09-012025-08-31 151061982024-08-31 15106198core:WithinOneYear2025-08-31 15106198core:WithinOneYear2024-08-31 15106198core:ShareCapitalcore:PreviouslyStatedAmount2025-08-31 15106198core:ShareCapitalcore:PreviouslyStatedAmount2024-08-31 15106198core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-08-31 15106198core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-08-31 15106198core:PreviouslyStatedAmount2025-08-31 15106198core:PreviouslyStatedAmount2024-08-31 15106198business:SmallEntities2024-09-012025-08-31 15106198countries:EnglandWales2024-09-012025-08-31 151061982023-08-302024-08-31 iso4217:GBP xbrli:pure
Company Registration No. 15106198 (England and Wales)
Bami Pharm Ltd Unaudited accounts for the year ended 31 August 2025
Bami Pharm Ltd Unaudited accounts Contents
Page
- 2 -
Bami Pharm Ltd Company Information for the year ended 31 August 2025
Director
Oluwadamilola Ige
Company Number
15106198 (England and Wales)
Registered Office
71-75 Shelton Street London WC2H 9JQ England
- 3 -
Bami Pharm Ltd Statement of financial position as at 31 August 2025
2025 
2024 
Notes
£ 
£ 
Current assets
Cash at bank and in hand
13,378 
10,193 
Creditors: amounts falling due within one year
(2,065)
(2,728)
Net current assets
11,313 
7,465 
Net assets
11,313 
7,465 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
11,312 
7,464 
Shareholders' funds
11,313 
7,465 
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 27 May 2026 and were signed on its behalf by
Oluwadamilola Ige Director Company Registration No. 15106198
- 4 -
Bami Pharm Ltd Notes to the Accounts for the year ended 31 August 2025
1
Statutory information
Bami Pharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 15106198. The registered office is 71-75 Shelton Street, London, WC2H 9JQ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Taxes and social security
902 
1,751 
Loans from directors
768 
582 
Accruals
395 
395 
2,065 
2,728 
5
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -